ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Ammonia → 4-oxo-8-(piperidin-4-ylsulfamoyl)-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline 1-propyl carboxylate

HRID 1970015
印刷

反応式

HRID 1970015 の反応式
C(N(CC)CC)C.C(OS(OCCC)(=O)=O)CC.C(OC([N:26]1[CH2:31][CH2:30][CH:29]([NH:32][S:33]([C:36]2[CH:45]=[CH:44][C:43]3[NH:42][C:41](=[O:46])[C:40]4[NH:47][CH:48]=[C:49]([C:50]([OH:52])=[O:51])[C:39]=4[C:38]=3[CH:37]=2)(=[O:35])=[O:34])[CH2:28][CH2:27]1)=O)(C)(C)C.N>CN(C)C=O.O>[O:46]=[C:41]1[C:40]2[NH:47][CH:48]=[CH:49][C:39]=2[C:38]2[CH:37]=[C:36]([S:33](=[O:35])(=[O:34])[NH:32][CH:29]3[CH2:28][CH2:27][NH:26][CH2:31][CH2:30]3)[CH:45]=[CH:44][C:43]=2[NH:42]1.[CH2:49]([C:50]([O-:52])=[O:51])[CH2:39][CH3:38]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 222AmmoniaHCID 8471Triethylamine2 回HCID 69015Sulfuric acid, dipropyl ester2 回HCID 689363828-(1-tert-butoxycarbonyl-piperidin-4-ylsulfamoyl)-4-oxo-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline-1-carboxylic acid

生成物 1

HCID 866275254-oxo-8-(piperidin-4-ylsulfamoyl)-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline 1-propyl carboxylate
収率 67.7%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

107 μL (0.76 mmol) of triethylamine and 100 μL (0.61 mmol) of di-n-propylsulfate are added to a solution of 150 mg (0.3 mmol) of 8-(1-tert-butoxycarbonyl-piperidin-4-ylsulfamoyl)-4-oxo-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline-1-carboxylic acid dissolved in 2 mL of anhydrous dimethylformamide. The solution is stirred at room temperature for 20 hours then 43 μL (0.3 mmol) of triethylamine and 51 μL (0.3 mmol) of di-n-propylsulfate are added again. Stirring is continued for a further 24 hours and 3 mL of ammonia is added. After stirring for a further 15 minutes, water is added and the product is extracted with dichloromethane. The organic phases are dried over magnesium sulfate, filtered then evaporated. The residue is dissolved in 2 mL of dichloroethane and 1 mL of trifluoroacetic acid. The solution is stirred at room temperature for 1 hour then the solvents are evaporated. The solid is taken up in dichloromethane then triethylamine is added to release the amine. The solvents are evaporated again and the residue is purified by chromatography on silica (eluent chloroform/methanol/ammonia 160/25/4) to give 44 mg (33% in two stages) of 4-oxo-8-(piperidin-4-ylsulfamoyl)-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline-1-propyl carboxylate in the form of a white solid.

後処理

  1. stirringStirring
  2. waitis continued for a further 24 hours
  3. stirringAfter stirring for a further 15 minutes
  4. extractionthe product is extracted with dichloromethane
  5. dry with materialThe organic phases are dried over magnesium sulfate
  6. filtrationfiltered
  7. customthen evaporated
  8. dissolutionThe residue is dissolved in 2 mL of dichloroethane
  9. stirringThe solution is stirred at room temperature for 1 hour
  10. customthe solvents are evaporated
  11. additiontriethylamine is added
  12. customThe solvents are evaporated again
  13. customthe residue is purified by chromatography on silica (eluent chloroform/methanol/ammonia 160/25/4)

出典と根拠

ORDレコード
ord-4d714a8693a64877b203eba81a477356
出典データセット
uspto-grants-2013_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08426437B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート